182 related articles for article (PubMed ID: 24802709)
1. A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns.
Borelli I; Casalis Cavalchini GC; Del Peschio S; Micheletti M; Venesio T; Sarotto I; Allavena A; Delsedime L; Barberis MA; Mandrile G; Berchialla P; Ogliara P; Bracco C; Pasini B
Fam Cancer; 2014 Sep; 13(3):401-13. PubMed ID: 24802709
[TBL] [Abstract][Full Text] [Related]
2. Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.
Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
Am J Surg Pathol; 2015 Aug; 39(8):1114-20. PubMed ID: 25871621
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome.
Alvarez K; Hurtado C; Hevia MA; Wielandt AM; de la Fuente M; Church J; Carvallo P; López-Köstner F
Dis Colon Rectum; 2010 Apr; 53(4):450-9. PubMed ID: 20305446
[TBL] [Abstract][Full Text] [Related]
4. Analysis of mismatch repair gene mutations in Turkish HNPCC patients.
Tunca B; Pedroni M; Cecener G; Egeli U; Borsi E; Zorluoglu A; Di Gregorio C; Yilmazlar T; Yerci O; de Leon MP
Fam Cancer; 2010 Sep; 9(3):365-76. PubMed ID: 20373145
[TBL] [Abstract][Full Text] [Related]
5. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
[TBL] [Abstract][Full Text] [Related]
6. [Founder mutation in Lynch syndrome].
Cajal AR; Piñero TA; Verzura A; Santino JP; Solano AR; Kalfayan PG; Ferro A; Vaccaro C
Medicina (B Aires); 2016; 76(3):180-2. PubMed ID: 27295708
[TBL] [Abstract][Full Text] [Related]
7. Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome.
Zighelboim I; Powell MA; Babb SA; Whelan AJ; Schmidt AP; Clendenning M; Senter L; Thibodeau SN; de la Chapelle A; Goodfellow PJ
Fam Cancer; 2009; 8(4):501-4. PubMed ID: 19672700
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer.
de Leon MP; Benatti P; Di Gregorio C; Losi L; Pedroni M; Ponti G; Genuardi M; Viel A; Lucci-Cordisco E; Rossi G; Roncucci L
Scand J Gastroenterol; 2007 Jun; 42(6):746-53. PubMed ID: 17505997
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases.
Mueller J; Gazzoli I; Bandipalliam P; Garber JE; Syngal S; Kolodner RD
Cancer Res; 2009 Sep; 69(17):7053-61. PubMed ID: 19690142
[TBL] [Abstract][Full Text] [Related]
10. A novel exonic rearrangement affecting MLH1 and the contiguous LRRFIP2 is a founder mutation in Portuguese Lynch syndrome families.
Pinheiro M; Pinto C; Peixoto A; Veiga I; Mesquita B; Henrique R; Baptista M; Fragoso M; Sousa O; Pereira H; Marinho C; Moreira Dias L; Teixeira MR
Genet Med; 2011 Oct; 13(10):895-902. PubMed ID: 21785361
[TBL] [Abstract][Full Text] [Related]
11. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
12. The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype.
Kwok CT; Vogelaar IP; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Rapkins RW; Ward RL; Chun N; Ford JM; Ladabaum U; McKinnon WC; Greenblatt MS; Hitchins MP
Eur J Hum Genet; 2014 May; 22(5):617-24. PubMed ID: 24084575
[TBL] [Abstract][Full Text] [Related]
13. Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome.
Castillejo A; Guarinos C; Martinez-Canto A; Barbera VM; Egoavil C; Castillejo MI; Perez-Carbonell L; Sanchez-Heras AB; Segura A; Ochoa E; Lazaro R; Ruiz-Ponte C; Bujanda L; Andreu M; Castells A; Carracedo A; Llor X; Clofent J; Alenda C; Paya A; Jover R; Soto JL
BMC Med Genet; 2011 Jan; 12():12. PubMed ID: 21247423
[TBL] [Abstract][Full Text] [Related]
14. Risk of cancer in cases of suspected lynch syndrome without germline mutation.
Rodríguez-Soler M; Pérez-Carbonell L; Guarinos C; Zapater P; Castillejo A; Barberá VM; Juárez M; Bessa X; Xicola RM; Clofent J; Bujanda L; Balaguer F; Reñé JM; de-Castro L; Marín-Gabriel JC; Lanas A; Cubiella J; Nicolás-Pérez D; Brea-Fernández A; Castellví-Bel S; Alenda C; Ruiz-Ponte C; Carracedo A; Castells A; Andreu M; Llor X; Soto JL; Payá A; Jover R
Gastroenterology; 2013 May; 144(5):926-932.e1; quiz e13-4. PubMed ID: 23354017
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.
Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C;
Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211
[TBL] [Abstract][Full Text] [Related]
16. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
18. Four novel germline mutations in the MLH1 and PMS2 mismatch repair genes in patients with hereditary nonpolyposis colorectal cancer.
Montazer Haghighi M; Radpour R; Aghajani K; Zali N; Molaei M; Zali MR
Int J Colorectal Dis; 2009 Aug; 24(8):885-93. PubMed ID: 19479271
[TBL] [Abstract][Full Text] [Related]
19. MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families.
Zhou HH; Yan SY; Zhou XY; Du X; Zhang TM; Cai X; Lu YM; Cai SJ; Shi DR
World J Gastroenterol; 2008 Dec; 14(48):7329-34. PubMed ID: 19109866
[TBL] [Abstract][Full Text] [Related]
20. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
